Loading...

Home
ETF
LRMR

LRMR

-

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

Overview Technical News

Most Trusted AI Platform for Winning Trades

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

Home
Contact
About Us
Press

Markets

Market Analysis
Crypto
Market Movers
Stock Monitor
Economic Calendar
All US Stocks
All Cryptos

AI Strategies

AI Stock Picker
Swing Trading
SwingMax Portfolio
Quant AI Alpha Pick
CoinSwing
Daytrading Center
Crypto Radar
Patterns Detection

Resources

Blog
Tutorial
Help Center
Affiliate Program

Products

Chat With Tia
AI Screener
Backtest Playground
Featured Screeners
AI Earnings Calendar
Thematic Investing
Whales Auto Tracker

Tools

Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Features

Explore AI Stock Picker
Master Swing Trading
Follow SwingMax Portfolio
Discover QuantAI Alpha Pick
Follow Whales Auto Tracker
Navigate Daytrading Center
Learn Patterns Detection
Meet Financial AI Agent
Maximize AI Screener
Why Backtesting Playground
Forecast AI Earnings Prediction
Setup Stock Monitor
Deep Dive into Tech Analysis

News

Overview
Top News
Daily Market Brief
Earnings Analysis
Newswire
Stock News
Crypto News
Institution News
Congress News
Monitor News

Compare

TradingView
SeekingAlpha

LRMR News

Larimar to Present at 44th J.P. Morgan Healthcare Conference on January 14, 2026

Dec 18 2025Globenewswire

Three Health Care Stocks Poised for Significant Gains This December

Dec 03 2025Benzinga

LRMR Investors Can Participate in Larimar Therapeutics, Inc. Fraud Investigation Led by Schall Law Firm

Oct 29 2025Globenewswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Larimar Therapeutics, Inc. - LRMR

Oct 23 2025PRnewswire

Larimar Therapeutics, Inc. Under Investigation for Securities Fraud - Reach Out to DJS Law Group to Understand Your Rights – LRMR

Oct 16 2025Newsfilter

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Larimar Therapeutics, Inc. - LRMR

Oct 08 2025PRnewswire

Top Analysts Recommend 3 Best Stocks to Purchase Now, 10/6/2025

Oct 06 2025TipRanks

Wednesday's Top Sectors: Biotechnology and Transportation Services

Oct 01 2025NASDAQ.COM

Top Analysts Recommend 3 Best Stocks to Purchase as of September 30, 2025

Sep 30 2025TipRanks

Wedbush Keeps Outperform Rating for Larimar Therapeutics, Adjusts Price Target to $11

Sep 30 2025Benzinga

Baird Keeps Outperform Rating for Larimar Therapeutics, Reduces Price Target to $7

Sep 30 2025Benzinga

Larimar Therapeutics Shares Decline Following Patient Allergic Reactions in Key Study

Sep 29 2025Benzinga

Larimar Therapeutics Reports Encouraging Results from Long-term Open Label Study and Provides Updates on Nomlabofusp Program for Friedreich's Ataxia

Sep 29 2025Newsfilter

Merus Shares Surge 38%; Check Out 20 Stocks Making Moves in Premarket Trading

Sep 29 2025Benzinga

Larimar Therapeutics to Host Conference Call Regarding Nomlabofusp Program for Friedreich's Ataxia Treatment

Sep 28 2025Newsfilter

Top Analysts Recommend 3 Best Stocks to Purchase as of September 1, 2025

Sep 01 2025TipRanks